METTL14 and postmenopausal osteoporosis: In summary, our results illustrate that miR‐103‐3p plays critical roles in postmenopausal osteoporosis by inhibiting osteoblast activity and bone formation and reveal a previously unrecognized signaling axis involving miR‐103‐3p/METTL14/m6A in osteoblasts.